News and Updates

New Phase 1 data for HCW9302 suggests promising safety and early activity in treating alopecia areata through targeted IL-2Rα-biased immunotherapy.

Neumora Therapeutics cuts staff after three failed MDD clinical trials for navacaprant. Learn how the company is restructuring to protect its pipeline.

The FDA and UK’s MHRA have launched a new liaison program to accelerate medical innovation and align global drug regulatory standards for improved patient care.

Maharashtra boosts public health with a new rural water policy and the launch of a high-tech Nagpur Medical Cyclotron Project for advanced cancer diagnosis.

Intelligent Bio Solutions begins a vital clinical study to secure FDA clearance, paving the way for a major expansion into the US healthcare market.

The FDA has approved SKINVIVE by JUVÉDERM for neck rejuvenation. Learn how this hyaluronic acid treatment improves skin smoothness and radiance.

The FDA has expanded the use of belzutifan for advanced renal cell carcinoma. Learn about the clinical trial data, HIF-2α inhibition, and patient outcomes.

USC has launched a new clinical trial to test psilocybin for mental health. Explore how this psychedelic-assisted therapy could redefine psychiatric care.

Discover how strategic collaborations are revolutionizing early-phase clinical research to accelerate the drug development pipeline and improve patient care.

Haryana plans a ₹10,000 crore boost for the Pharma and MedTech sectors. Discover how this move aims to cut import reliance and foster domestic innovation.